Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) EBIT (2023 - 2025)

SeaStar Medical Holding filings provide 3 years of EBIT readings, the most recent being $6.6 million for Q4 2025.

  • On a quarterly basis, EBIT rose 238.62% to $6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.5 million, a 85.71% increase, with the full-year FY2025 number at -$2.6 million, up 85.7% from a year prior.
  • EBIT hit $6.6 million in Q4 2025 for SeaStar Medical Holding, up from -$3.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $6.6 million in Q4 2025 to a low of -$4.8 million in Q4 2024.
  • Median EBIT over the past 3 years was -$3.8 million (2023), compared with a mean of -$2.9 million.
  • Biggest five-year swings in EBIT: tumbled 62.31% in 2024 and later skyrocketed 238.62% in 2025.
  • SeaStar Medical Holding's EBIT stood at -$2.9 million in 2023, then tumbled by 62.31% to -$4.8 million in 2024, then skyrocketed by 238.62% to $6.6 million in 2025.
  • The last three reported values for EBIT were $6.6 million (Q4 2025), -$3.6 million (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.